-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Downgrades Tenet Healthcare to Neutral, Lowers Price Target to $140

Benzinga·12/16/2024 10:56:09
Listen to the news
Goldman Sachs analyst Jamie Perse downgrades Tenet Healthcare (NYSE:THC) from Buy to Neutral and lowers the price target from $196 to $140.